Noofambar 18-keedii, ThyssenKrupp (oo hadda loo yaqaan Thyssen) ayaa ku dhawaaqay in kasta oo saameynta cudurka faafa ee pneumonia-ka cusub uu wali jiro, taasoo ay sabab u tahay kororka qiimaha birta, rubuci afaraad ee shirkadda sanad maaliyadeedka 2020-2021 (Julaay 2021 ~ Sebtember 2021) ) Iibku waxa uu ahaa 9.44 bilyan oo Yuuro (qiyaastii 10.68 bilyan oo doolarka Maraykanka ah), korodhka 1.49 bilyan yuuro marka loo eego 7.95 bilyan oo Yuuro isla muddadaas sannadkii hore;Faa'iidada cashuurta ka hor waxay ahayd 232 milyan oo Yuuro, faa'iidada saafiga ahna waxay ahayd 1.16 Bilyan oo Yuuro.
Thyssen ayaa sheegay in dakhliga soo gala dhammaan qaybaha ganacsiga ee shirkadu uu aad u kordhay, iyo soo kabashada baahida suuqa ayaa saamayn togan ku yeelatay qaybteeda ganacsiga birta ee Yurub.
Intaa waxaa dheer, Thyssen waxay dejisay yoolalka waxqabadka gardarada ah ee sanad xisaabeedka 2021-2022.Shirkaddu waxay qorshaynaysaa inay kordhiso faa'iidada saafiga ah ilaa 1 bilyan oo Yuuro sannad maaliyadeedka soo socda.(Tian Chenyang)